--- schema_version: "secwatch.filing_event.v1" accession: "0001104659-24-062503" form_type: "8-K" ticker: "BCYC" cik: "0001761612" company_name: "BICYCLE THERAPEUTICS PLC" filed_at: "2024-05-16T23:59:59+00:00" generated_at: "2026-06-01T21:33:22.614116+00:00" event_type: "other" sentiment: "neutral" materiality_score: 0.25 calibrated_materiality_score: 0.15 confidence: "high" source: SEC EDGAR --- # Bicycle Therapeutics shareholders approve all 11 proposals at 2024 AGM ## Summary - Directors Kevin Lee (36.4M for) and Jose-Carlos Gutierrez-Ramos (35.0M for) re-elected. - Advisory vote on executive compensation passed with 36.2M for, 1.2M against. - Ratification of PwC as US and UK auditors approved with ~37.4M for each. - Share allotment authorization and pre-emption rights disapplication passed with >32M for each. - New articles of association adopted with 37.4M for, 15,138 against. ## SEC filing metadata - accession: 0001104659-24-062503 - form_type: 8-K - ticker: BCYC - cik: 0001761612 - company_name: BICYCLE THERAPEUTICS PLC - filed_at: 2024-05-16T23:59:59+00:00 - event_type: other - sentiment: neutral - materiality_score: 0.25 - calibrated_materiality_score: 0.15 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/tm2414682d1_8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001104659-24-062503 - JSON: https://secwatch.observer/filing/0001104659-24-062503.json - Plain text: https://secwatch.observer/filing/0001104659-24-062503.txt ## Source-grounded claims - claim_id: 07798c60cdcde08718df86944911e954158040be claim: BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration report for the year ended December 31, 2023. at the 2024-05-16 meeting. evidence_excerpt: Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: 40bec102583ed2d2289a3e5c0c05d3d1fdfcc922 claim: BICYCLE THERAPEUTICS PLC shareholders approved To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association. at the 2024-05-16 meeting. evidence_excerpt: Proposal 11 – To adopt the new articles of association in substitution for, and to the exclusion of, the Company’s existing articles of association. For Against Vote Withheld/Abstain 37,371,711 15,138 11,258 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: 419297d81db825634cb37b3c06270d7f6b083dda claim: BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Audit Committee of the Company's Board of Directors to determine the Company's U.K. statutory auditors' remuneration for the year ending December 31, 2024. at the 2024-05-16 meeting. evidence_excerpt: Proposal 6 – To authorize the Audit Committee of the Company’s Board of Directors (the “Board”) to determine the Company’s U.K. statutory auditors’ remuneration for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,455 14,150 7,502 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: 558cc14f370e2a956ff95ac90ef9c651c681c1ae claim: BICYCLE THERAPEUTICS PLC shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement. at the 2024-05-16 meeting. evidence_excerpt: Proposal 3 – To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement. For Against Vote Withheld/Abstain 36,186,115 1,202,477 9,515 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: 9713dd0068a7cc44dcf2a51866ae6535e1cb5ad7 claim: BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. at the 2024-05-16 meeting. evidence_excerpt: Proposal 10 – To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. For Against Vote Withheld/Abstain 32,350,797 4,154,715 892,595 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: ad85b1ff154b6fb107385b755751233d10c2cb50 claim: BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. at the 2024-05-16 meeting. evidence_excerpt: Proposal 9 – To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. For Against Vote Withheld/Abstain 33,241,556 4,146,578 9,973 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: d2747917411399b0549191d9ab03c1cfc2a2a056 claim: BICYCLE THERAPEUTICS PLC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024. at the 2024-05-16 meeting. evidence_excerpt: Proposal 4 – To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,526 14,076 7,505 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: d769b58fb372be62bc9fb99c5e324d251812a4ea claim: BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Kevin Lee. at the 2024-05-16 meeting. evidence_excerpt: Proposal 1 – To re-elect as a director Kevin Lee. For Against Vote Withheld/Abstain 36,413,260 977,286 7,561 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: df0eb18b925049511adb3741c0489a75615b13e1 claim: BICYCLE THERAPEUTICS PLC shareholders approved To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2023. at the 2024-05-16 meeting. evidence_excerpt: Proposal 7 – To receive and adopt the Company’s U.K. statutory annual accounts and reports for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,494,043 896,166 7,898 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: e7ad26cba3d0c1c5fdc18b7c75b7a5cf6f273f85 claim: BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Jose-Carlos Gutierrez-Ramos. at the 2024-05-16 meeting. evidence_excerpt: Proposal 2 – To re-elect as a director Jose-Carlos Gutierrez-Ramos. For Against Vote Withheld/Abstain 35,019,069 2,371,385 7,653 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm - claim_id: f96cd3195df0281cd26a4d3b182fb848e2569bfe claim: BICYCLE THERAPEUTICS PLC shareholders approved To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. at the 2024-05-16 meeting. evidence_excerpt: Proposal 5 – To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. For Against Vote Withheld/Abstain 37,376,531 14,071 7,505 evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.